Atul Dandekar, CSBO at Maze Therapeutics, Inc. (MAZE), sold 7,500 shares at $26.34 ($198K) on 2026-05-29, disclosed to the SEC on 2026-06-02.
Scheduled sale ($198k) by CSBO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MAZE | SELL | 2026-08-31 | $207K | — | Filing → |
| MAZE | SELL | 2026-07-31 | $205K | — | Filing → |
| MAZE | SELL | 2026-07-01 | $210K | — | Filing → |